Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Giulia Mosconi

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Stroke|June 22, 2019
Anticoagulation After Stroke in Patients With Atrial FibrillationRiccardo Altavilla, Valeria Caso, Fabio Bandini, et al.
Stroke|June 26, 2019
Causes and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants for Stroke PreventionMaurizio Paciaroni, Giancarlo Agnelli, Valeria Caso, et al.
European Stroke Journal|February 18, 2021
Timing of initiation of oral anticoagulants in patients with acute ischemic stroke and atrial fibrillation comparing posterior and anterior circulation strokesMaurizio Paciaroni, Giancarlo Agnelli, Michela Giustozzi, et al.
Stroke|December 9, 2024
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study CohortMatteo Foschi, Lucio D'Anna, Eleonora De Matteis, et al.
JAMA Network Open|April 28, 2026
Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough StrokeLucio D'Anna, Francesca Gabriele, Raffaele Ornello, et al.
Journal of the Neurological Sciences|August 7, 2025
Characteristics and causes of recurrent ischemic events in minor ischemic stroke and TIA in the READAPT studyFederico De Santis, Matteo Foschi, Michele Romoli, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 19, 2026
Early versus Late starting of Direct Oral Anticoagulants after breakthrough ischemic stroke: A Target Trial Analysis from the ASPERA-R StudyLucio D'Anna, Matteo Foschi, Francesca Gabriele, et al.
Stroke|February 11, 2017
Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients With Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema: The ALESSA Score StudyMaurizio Paciaroni, Giancarlo Agnelli, Valeria Caso, et al.
European Stroke Journal|February 27, 2026
Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R studyMatteo Foschi, Federico De Santis, Francesca Gabriele, et al.
Journal of the American Heart Association|March 31, 2026
Sex Differences in Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants for Atrial Fibrillation: An ASPERA-R Inverse Probability Weighted AnalysisMatteo Foschi, Lucio D'Anna, Francesca Gabriele, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Stroke|June 22, 2019
Anticoagulation After Stroke in Patients With Atrial FibrillationRiccardo Altavilla, Valeria Caso, Fabio Bandini, et al.
Stroke|June 26, 2019
Causes and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants for Stroke PreventionMaurizio Paciaroni, Giancarlo Agnelli, Valeria Caso, et al.
European Stroke Journal|February 18, 2021
Timing of initiation of oral anticoagulants in patients with acute ischemic stroke and atrial fibrillation comparing posterior and anterior circulation strokesMaurizio Paciaroni, Giancarlo Agnelli, Michela Giustozzi, et al.
Stroke|December 9, 2024
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study CohortMatteo Foschi, Lucio D'Anna, Eleonora De Matteis, et al.
JAMA Network Open|April 28, 2026
Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough StrokeLucio D'Anna, Francesca Gabriele, Raffaele Ornello, et al.
Journal of the Neurological Sciences|August 7, 2025
Characteristics and causes of recurrent ischemic events in minor ischemic stroke and TIA in the READAPT studyFederico De Santis, Matteo Foschi, Michele Romoli, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 19, 2026
Early versus Late starting of Direct Oral Anticoagulants after breakthrough ischemic stroke: A Target Trial Analysis from the ASPERA-R StudyLucio D'Anna, Matteo Foschi, Francesca Gabriele, et al.
Stroke|February 11, 2017
Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients With Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema: The ALESSA Score StudyMaurizio Paciaroni, Giancarlo Agnelli, Valeria Caso, et al.
European Stroke Journal|February 27, 2026
Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R studyMatteo Foschi, Federico De Santis, Francesca Gabriele, et al.
Journal of the American Heart Association|March 31, 2026
Sex Differences in Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants for Atrial Fibrillation: An ASPERA-R Inverse Probability Weighted AnalysisMatteo Foschi, Lucio D'Anna, Francesca Gabriele, et al.
Pageof 6